Fukuoka, Kurume, Japan Clinical Trials

A listing of Fukuoka, Kurume, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy

The primary objectives of this study are to examine the clinical efficacy of nusinersen administered intrathecally at higher doses to participants with SMA, as measured by change in Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) total score (Part B); to examine the safety and tolerability of …

gene deletion
nusinersen
muscle atrophy
Kurume University Hospital
 (0.6 away) Contact site
  • 42 views
  • 03 Jun, 2021
  • +46 other locations
Efficacy & Safety of TD-1473 in Ulcerative Colitis

A Phase 2b/3 set of studies to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473 in subjects with moderately-to-severely active ulcerative colitis with up to 60 weeks of treatment.

aminosalicylates
corticosteroids
immunomodulators
Theravance Biopharma Investigational Site
 (2.5 away) Contact site
  • 75 views
  • 28 Jan, 2021
  • +202 other locations
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease.

crohn's disease
colitis
ileitis
fistulising crohn's disease
endoscopy
Kurume University Hospital
 (0.6 away) Contact site
  • 792 views
  • 16 Jun, 2021
  • +795 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Kurume University Hospital /ID# 164427
 (0.6 away) Contact site
  • 604 views
  • 16 Jun, 2021
  • +772 other locations
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

The primary objective of the study is to determine if treatment with high-dose aflibercept (HD) at intervals of 12 or 16 weeks provides non-inferior best corrected visual acuity (BCVA) compared to aflibercept dosed every 8 weeks. The secondary objectives of the study are as follows: To determine the effect of …

visual impairment
diabetic macular edema
corrected visual acuity
retinopathy
diabetic retinopathy
Regeneron Study Site
 (0.6 away) Contact site
  • 17 views
  • 14 May, 2021
  • +199 other locations
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

A 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis who have participated in the Maintenance Study of Protocol 0157

remission
Theravance Biopharma Investigational Site
 (2.5 away) Contact site
  • 7 views
  • 28 Jan, 2021
  • +158 other locations
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia Followed by an Open-label Extension Phase

A clinical study to investigate the effect of 2 doses of an investigational drug in acutely psychotic adult patients with schizophrenia. The study will consist of a double-blind phase followed by an open-label extension phase.

NHO Hizen Psychiatric Center
 (7.7 away) Contact site
  • 0 views
  • 11 Apr, 2021
  • +24 other locations